Vivalink’s CEO Jiang Li, PhD, discusses the importance of including as much information with clinical data as possible.
Jiang Li
Advertisement
Jiang Li is CEO of Vivalink.
Articles by Jiang Li
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
How Does FDA's Single Trial Decision Change The Risk Calculus for Sponsors
3
What is Shadow AI and How is it Impacting Pharma Companies?
4
Conflict in Middle East Disrupts Pharma Drug Supplies: Report
5